CHIAMAKA ANOSIKE: Open Payments
NPI 1407594757 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 21 payments from 11 companies in 2025. Trend: 2023 $133 · 2024 $0 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $150 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Neurocrine BioSciences, Inc. | 2 | $59 |
| Lundbeck LLC | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Alkermes, Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $21 |
Products named: UZEDY, COBENFY, REXULTI, INGREZZA, ABILIFY MAINTENA, ARISTADA, VRAYLAR, INVEGA SUSTENNA.
Industry payments across GA — which companies pay providers there.
